Hangzhou Andao Pharmaceutical

Developer of therapeutics for the treatment of cancer and kidney diseases

placeHangzhou, Zhejiang, China calendar_todayFounded 2014 language kindpharmaceuticals.com

Innovation

7 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 16 times.

YearFilings
20182
20211
20221
20231
20253

Investor mix

6 investors on record; lead investors include NLVC, Gaorong Capital.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon